ENDRA Life Sciences Inc. (NDRA)

ENDRA Life Sciences Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year	Current	2023	2022	2021	2020	2019
Market Capitalization	6	18	13	29	19	13
Market Cap Growth	-11.80%	39.42%	-55.93%	54.93%	49.09%	55.17%
Enterprise Value	5	15	9	20	12	7
PE Ratio	-	-1.78	-0.97	-2.57	-1.55	-0.72
PB Ratio	1.69	3.17	1.78	2.71	2.63	2.65
P/FCF Ratio	-0.70	-1.87	-0.99	-2.61	-1.74	-1.46
P/OCF Ratio	-0.70	-1.88	-1.01	-2.62	-1.75	-1.47
EV/EBITDA Ratio	-0.58	-1.58	-0.66	-1.85	-1.06	-0.54
EV/EBIT Ratio	-0.57	-1.54	-0.65	-1.82	-1.05	-0.54
EV/FCF Ratio	-0.61	-1.62	-0.66	-1.83	-1.14	-0.83
Debt / Equity Ratio	0.09	0.07	0.08	0.06	0.10	0.15
Debt / EBITDA Ratio	-0.03	-0.04	-0.04	-0.06	-0.06	-0.05
Debt / FCF Ratio	-0.04	-0.04	-0.04	-0.06	-0.06	-0.08
Quick Ratio	0.93	3.14	2.87	6.13	7.33	2.98
Current Ratio	1.04	3.36	3.16	7.83	8.32	3.15
Return on Equity (ROE)	-184.20%	-180.60%	-132.40%	-80.00%	-346.20%	-594.60%
Return on Assets (ROA)	-138.10%	-133.00%	-110.10%	-70.60%	-226.70%	-376.50%
Return on Capital (ROIC)	-257.82%	-173.80%	-169.75%	-99.94%	-146.54%	-196.36%
Earnings Yield	-157.83%	-56.13%	-102.51%	-38.92%	-64.38%	-138.78%
FCF Yield	-146.89%	-53.41%	-100.90%	-38.28%	-57.48%	-68.36%
Buyback Yield / Dilution	-240.94%	-120.10%	-41.31%	-113.23%	-155.90%	-66.49%
Total Shareholder Return	-240.94%	-120.10%	-41.31%	-113.23%	-155.90%	-66.49%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).